abstract |
The invention relates to novel naphthyl-substituted and anilide-substituted sulfonamides of general formula (I), wherein the substituents A, D, E, G, R<1>, R<2>, R<3>, R<4> and X have the meanings given in the description. The invention also relates to the production of said sulfonamides and the utilization thereof as antiviral agents, especially for combating cytomegaloviruses. |